Literature DB >> 10818541

Contrast-enhanced MRI of white matter lesions in patients with blood-brain barrier dysfunction.

L O Wahlund1, L Bronge.   

Abstract

White matter lesions (WMLs) and blood-brain barrier (BBB) dysfunction are common in dementia. Both conditions may be a consequence of small-vessel disease, in which case the BBB damage could be suspected to be located to the WMLs. Magnetic resonance imaging (MRI) can be used to show WMLs as well as to detect BBB damage when using an intravenous contrast agent, gadolinium. We examined 10 demented patients with WMLs, including 5 cases with BBB (elevated CSF/serum albumin ratios). Results showed no significant changes in MR signal in the WMLs after contrast administration. We conclude that WMLs are not related to BBB damage to such a degree that is detectable with this method and that the elevated CSF albumin might have another origin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818541     DOI: 10.1111/j.1749-6632.2000.tb06402.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging.

Authors:  J M Starr; J Wardlaw; K Ferguson; A MacLullich; I J Deary; I Marshall
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease.

Authors:  Sonia Chalbot; Henrik Zetterberg; Kaj Blennow; Tormod Fladby; Niels Andreasen; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 3.  Brain imaging of neurovascular dysfunction in Alzheimer's disease.

Authors:  Axel Montagne; Daniel A Nation; Judy Pa; Melanie D Sweeney; Arthur W Toga; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2016-04-01       Impact factor: 17.088

4.  Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability.

Authors:  Anna K Heye; Michael J Thrippleton; Paul A Armitage; Maria Del C Valdés Hernández; Stephen D Makin; Andreas Glatz; Eleni Sakka; Joanna M Wardlaw
Journal:  Neuroimage       Date:  2015-10-20       Impact factor: 6.556

5.  Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities.

Authors:  Paul A Armitage; Andrew J Farrall; Trevor K Carpenter; Fergus N Doubal; Joanna M Wardlaw
Journal:  Magn Reson Imaging       Date:  2010-10-27       Impact factor: 2.546

Review 6.  Multiple Factors Involved in the Pathogenesis of White Matter Lesions.

Authors:  Jing Lin; Dilong Wang; Linfang Lan; Yuhua Fan
Journal:  Biomed Res Int       Date:  2017-02-21       Impact factor: 3.411

Review 7.  Pathogenesis and research progress in leukoaraiosis.

Authors:  Lingqi Sun; Lin Hui; Yi Li; Xian Chen; Rong Liu; Ji Ma
Journal:  Front Hum Neurosci       Date:  2022-08-19       Impact factor: 3.473

8.  Strategies for molecular imaging dementia and neurodegenerative diseases.

Authors:  Bernhard J Schaller
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

9.  Role of Hyperintense Acute Reperfusion Marker for Classifying the Stroke Etiology.

Authors:  Hee Young Choi; Kyung Mi Lee; Hyug-Gi Kim; Eui Jong Kim; Woo Suk Choi; Bum Joon Kim; Sung Hyuk Heo; Dae-Il Chang
Journal:  Front Neurol       Date:  2017-11-29       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.